HyperMed Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

HyperMed General Information

Description

Developer of medical imaging devices designed to deliver diagnostic information in a smaller, portable configuration. The company's devices use a proprietary spectrometer to measure light absorption in blood molecules to determine levels of oxyhemoglobin and deoxyhemoglobin and oxygen saturation in superficial tissue and provide data and a color-coded map of tissue oximetry values, enabling clinical practitioners to improve the lives of patients suffering from complications of vascular disease and diabetes.

Contact Information

Formerly Known As
Hyperspectral Imaging
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 8700 Trail Lake Drive West
  • Suite 200
  • Memphis, TN 38125
  • United States
+1 (203)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Parent Company
Vertical(s)
Corporate Office
  • 8700 Trail Lake Drive West
  • Suite 200
  • Memphis, TN 38125
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HyperMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 11-May-2025 Completed Generating Revenue
6. Later Stage VC (Series C) 04-Apr-2018 Completed Generating Revenue
5. Later Stage VC 01-Dec-2014 Completed Generating Revenue
4. Restart - Later VC 23-Dec-2011 Completed Restart
3. Bankruptcy: Admin/Reorg 23-Dec-2009 Completed Bankruptcy: Admin/Reorg
2. Later Stage VC (Series B) 23-May-2008 $4M $9M Completed Generating Revenue
1. Later Stage VC (Series A) 28-Feb-2007 $5M $5M Completed Generating Revenue
To view HyperMed’s complete valuation and funding history, request access »

HyperMed Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 11,801,666 $0.001000 8% $1 $1 1x $1 31.45%
To view HyperMed’s complete cap table history, request access »

HyperMed Patents

HyperMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3176544-A1 Portable hyperspectral imaging device Pending 23-Apr-2020
US-20230157549-A1 Portable hyperspectral imaging device Inactive 23-Apr-2020
WO-2021216922-A1 Portable hyperspectral imaging device Inactive 23-Apr-2020
CA-3112470-A1 Hyperspectral imaging method and device Pending 13-Sep-2018
EP-3849659-A1 Hyperspectral imaging method and device Inactive 13-Sep-2018 G01J3/2823
To view HyperMed’s complete patent history, request access »

HyperMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HyperMed Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biomark Capital PE/Buyout Minority
Burrill & Co Merchant Banking Firm Minority
Dws Investment Asset Manager Minority
Kluz Ventures Venture Capital Minority
To view HyperMed’s complete investors history, request access »

HyperMed FAQs

  • When was HyperMed founded?

    HyperMed was founded in 1997.

  • Where is HyperMed headquartered?

    HyperMed is headquartered in Memphis, TN.

  • What is the size of HyperMed?

    HyperMed has 7 total employees.

  • What industry is HyperMed in?

    HyperMed’s primary industry is Diagnostic Equipment.

  • Is HyperMed a private or public company?

    HyperMed is a Private company.

  • What is HyperMed’s current revenue?

    The current revenue for HyperMed is .

  • How much funding has HyperMed raised over time?

    HyperMed has raised $18.6M.

  • Who are HyperMed’s investors?

    Biomark Capital, Burrill & Co, Dws Investment, and Kluz Ventures have invested in HyperMed.

  • When was HyperMed acquired?

    HyperMed was acquired on 11-May-2025.

  • Who acquired HyperMed?

    HyperMed was acquired by SafetySpect.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process